Your browser doesn't support javascript.
loading
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.
Benedetti, Sara; Uno, Narumi; Hoshiya, Hidetoshi; Ragazzi, Martina; Ferrari, Giulia; Kazuki, Yasuhiro; Moyle, Louise Anne; Tonlorenzi, Rossana; Lombardo, Angelo; Chaouch, Soraya; Mouly, Vincent; Moore, Marc; Popplewell, Linda; Kazuki, Kanako; Katoh, Motonobu; Naldini, Luigi; Dickson, George; Messina, Graziella; Oshimura, Mitsuo; Cossu, Giulio; Tedesco, Francesco Saverio.
Afiliação
  • Benedetti S; Department of Cell and Developmental Biology, University College London, London, UK.
  • Uno N; Great Ormond Street Institute of Child Health, University College London, London, UK.
  • Hoshiya H; Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Tottori University, Yonago, Tottori, Japan.
  • Ragazzi M; Chromosome Engineering Research Center (CERC), Tottori University, Yonago, Tottori, Japan.
  • Ferrari G; Department of Cell and Developmental Biology, University College London, London, UK.
  • Kazuki Y; Department of Cell and Developmental Biology, University College London, London, UK.
  • Moyle LA; Department of Cell and Developmental Biology, University College London, London, UK.
  • Tonlorenzi R; Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Tottori University, Yonago, Tottori, Japan.
  • Lombardo A; Chromosome Engineering Research Center (CERC), Tottori University, Yonago, Tottori, Japan.
  • Chaouch S; Department of Cell and Developmental Biology, University College London, London, UK.
  • Mouly V; Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, Milan, Italy.
  • Moore M; San Raffaele Telethon Institute for Gene Therapy (TIGET), San Raffaele Scientific Institute and Vita Salute San Raffaele University, Milan, Italy.
  • Popplewell L; AIM/AFM Center for Research in Myology, Sorbonne Universités, UPMC Univ. Paris 06, INSERM UMRS974, CNRS FRE3617, Paris, France.
  • Kazuki K; AIM/AFM Center for Research in Myology, Sorbonne Universités, UPMC Univ. Paris 06, INSERM UMRS974, CNRS FRE3617, Paris, France.
  • Katoh M; School of Biological Sciences, Royal Holloway-University of London, Egham, Surrey, UK.
  • Naldini L; School of Biological Sciences, Royal Holloway-University of London, Egham, Surrey, UK.
  • Dickson G; Chromosome Engineering Research Center (CERC), Tottori University, Yonago, Tottori, Japan.
  • Messina G; Chromosome Engineering Research Center (CERC), Tottori University, Yonago, Tottori, Japan.
  • Oshimura M; Department of Biosciences, University of Milan, Milan, Italy.
  • Cossu G; School of Biological Sciences, Royal Holloway-University of London, Egham, Surrey, UK.
  • Tedesco FS; Department of Biosciences, University of Milan, Milan, Italy.
EMBO Mol Med ; 10(2): 254-275, 2018 02.
Article em En | MEDLINE | ID: mdl-29242210
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Distrofina / Distrofia Muscular de Duchenne / Cromossomos Artificiais Humanos Limite: Animals / Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Distrofina / Distrofia Muscular de Duchenne / Cromossomos Artificiais Humanos Limite: Animals / Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido